Literature DB >> 21345820

A survey of opinions and beliefs concerning surgery for malignant pleural mesothelioma amongst 802 members of the European Association for Cardio-Thoracic Surgery (EACTS), the European Society of Thoracic Surgeons (ESTS) and the Society of Thoracic Surgeons (STS).

Tom Treasure, Eveline Internullo, Francesca Fiorentino, Dirk Van Raemdonck, Paul Van Schil, Malcolm Decamp, Douglas Wood, Martin Utley.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21345820     DOI： 10.1510/icvts.2010.251488

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN： 1569-9285


× No keyword cloud information.
  7 in total

1.  Safety and efficacy of trimodality therapy in patients undergoing extrapleural pneumonectomy.

Authors:  Servet Bölükbas
Journal:  Chin J Cancer Res       Date:  2013-04       Impact factor: 5.087

2.  Treatment of malignant pleural mesothelioma: lessons learned and quo vadis?

Authors:  Servet Bölükbas; Michael Eberlein
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

3.  Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database.

Authors:  Robert Ryan Meyerhoff; Chi-Fu Jeffrey Yang; Paul J Speicher; Brian C Gulack; Matthew G Hartwig; Thomas A D'Amico; David H Harpole; Mark F Berry
Journal:  J Surg Res       Date:  2015-01-29       Impact factor: 2.192

Review 4.  [Malignant pleural mesothelioma: comparison of radical pleurectomy und extrapleural pneumonectomy].

Authors:  S Bölükbas; J Schirren
Journal:  Chirurg       Date:  2013-06       Impact factor: 0.955

Review 5.  Malignant pleural mesothelioma: current and future perspectives.

Authors:  Konstantinos Porpodis; Paul Zarogoulidis; Efimia Boutsikou; Antonis Papaioannou; Nikolaos Machairiotis; Kosmas Tsakiridis; Nikolaos Katsikogiannis; Bojan Zaric; Branislav Perin; Haidong Huang; Ioanna Kougioumtzi; Dionysios Spyratos; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2013-09       Impact factor: 2.895

6.  Survival analysis via nomogram of surgical patients with malignant pleural mesothelioma in the Surveillance, Epidemiology, and End Results database.

Authors:  Minglei Zhuo; Qiwen Zheng; Yujia Chi; Bo Jia; Jun Zhao; Meina Wu; Tongtong An; Yuyan Wang; Jianjie Li; Xinghui Zhao; Xue Yang; Jia Zhong; Hanxiao Chen; Zhi Dong; Jingjing Wang; Xiaoyu Zhai; Ziping Wang
Journal:  Thorac Cancer       Date:  2019-04-05       Impact factor: 3.500

7.  Surgery in the treatment of malignant pleural mesothelioma: recruitment into trials should be the default position.

Authors:  Avijit Datta; Rhiannon Smith; Francesca Fiorentino; Tom Treasure
Journal:  Thorax       Date:  2013-06-12       Impact factor: 9.139
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.